Antoine Yver
Direktor/Vorstandsmitglied bei SANOFI
Vermögen: 4 Mio $ am 30.04.2024
Profil
Antoine Yver's current jobs include being the Executive Vice President & Chairman-Development at Centessa Pharmaceuticals Plc, an Independent Director at Sanofi, and a Director at Spotlight Therapeutics, Inc. Previously, he worked as a Senior Director at Aventis SA from 1990 to 2005, as an Executive Director at Schering-Plough SAS from 2006 to 2009, as a Senior Director at Johnson & Johnson Medical SAS from 2005 to 2006, as the Head-Global Medicines Development at AstraZeneca PLC from 2015 to 2016, and as the EVP, Global Head-Oncology Research and Development at Daiichi Sankyo Co., Ltd.
from 2016 to 2021.
Dr. Yver obtained his undergraduate and doctorate degrees from Université Paris-Saclay.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 19.03.2024 | 437 310 ( 0,49% ) | 4 Mio $ | 30.04.2024 |
Aktive Positionen von Antoine Yver
| Unternehmen | Position | Beginn |
|---|---|---|
| CENTESSA PHARMACEUTICALS PLC | Corporate Officer/Principal | 07.03.2022 |
| SANOFI | Direktor/Vorstandsmitglied | 03.05.2022 |
Spotlight Therapeutics, Inc.
 Spotlight Therapeutics, Inc. Pharmaceuticals: GenericHealth Technology Spotlight Therapeutics, Inc. engages in gene editing therapeutics. It focused in reprogramming tumor microenvironment. The company was founded by Alex Marson, Patrick Hsu, and Jacob Corn in 2017 and is headquartered in Hayward, CA. | Direktor/Vorstandsmitglied | 04.07.2022 |
Ehemalige bekannte Positionen von Antoine Yver
| Unternehmen | Position | Ende |
|---|---|---|
| DAIICHI SANKYO CO., LTD. | Corporate Officer/Principal | 01.04.2021 |
| ASTRAZENECA PLC | Corporate Officer/Principal | 01.01.2016 |
Schering-Plough SAS
 Schering-Plough SAS Pharmaceuticals: MajorHealth Technology Founded in 1900, Schering-Plough SAS is a French pharmaceutical company that manufactures pharmaceutical products. Part of Merck & Co., Inc., the company is based in Puteaux, France. | Corporate Officer/Principal | 01.01.2009 |
Johnson & Johnson Medical SAS
 Johnson & Johnson Medical SAS Medical DistributorsDistribution Services Part of Johnson & Johnson, Johnson & Johnson Medical SAS is a French company that wholesales pharmaceutical products. The company is based in Issy-les-Moulineaux, France. The CEO of the company is Myriam Martinez Climent. | Corporate Officer/Principal | 01.01.2006 |
Aventis SA
 Aventis SA Pharmaceuticals: MajorHealth Technology Aventis SA develops pharmaceuticals and vaccines for preventative medicine. The company is located in Schiltigheim, France. | Corporate Officer/Principal | 01.01.2005 |
Ausbildung von Antoine Yver
| Université Paris-Saclay | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 4 |
|---|---|
| ASTRAZENECA PLC | Health Technology |
| DAIICHI SANKYO CO., LTD. | Health Technology |
| CENTESSA PHARMACEUTICALS PLC | Health Technology |
| SANOFI | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Spotlight Therapeutics, Inc.
Spotlight Therapeutics, Inc. Pharmaceuticals: GenericHealth Technology Spotlight Therapeutics, Inc. engages in gene editing therapeutics. It focused in reprogramming tumor microenvironment. The company was founded by Alex Marson, Patrick Hsu, and Jacob Corn in 2017 and is headquartered in Hayward, CA. | Health Technology |
Aventis SA
Aventis SA Pharmaceuticals: MajorHealth Technology Aventis SA develops pharmaceuticals and vaccines for preventative medicine. The company is located in Schiltigheim, France. | Health Technology |
Johnson & Johnson Medical SAS
Johnson & Johnson Medical SAS Medical DistributorsDistribution Services Part of Johnson & Johnson, Johnson & Johnson Medical SAS is a French company that wholesales pharmaceutical products. The company is based in Issy-les-Moulineaux, France. The CEO of the company is Myriam Martinez Climent. | Distribution Services |
Schering-Plough SAS
Schering-Plough SAS Pharmaceuticals: MajorHealth Technology Founded in 1900, Schering-Plough SAS is a French pharmaceutical company that manufactures pharmaceutical products. Part of Merck & Co., Inc., the company is based in Puteaux, France. | Health Technology |
